CI · Large Cap · NYSE · Healthcare · Healthcare Plans
updated 3d ago
Free research brief
Free to track. No card required.
Overall score
70/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Current price
$277.47
Lowest
$290
Median target
$343
Highest
$400
Forward P/E
Favorable · 53% below avg
8.75x
Price / sales
Strong · Low price-to-sales
0.26x
Price / FCF
Strong · Cash flow supports price
8.05x
EV / EBITDA
Strong · Earnings support price
7.68x
Debt / equity
Favorable · 0.73 - solid leverage
0.74x
Current ratio
Weak · Low cash for bills
0.85x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $73.33B | 11.5 | +7.8% | 70 | |
| $11.67B | 22.2 | +19.7% | 78 | |
| $4.35B | 13.1 | +13.5% | 77 | |
| $34.85B | 36.5 | +15.5% | 77 | |
| $1.18T | 42.7 | +49.6% | 76 |